These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 21127264)
1. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole SA; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Baglietto L; Giles GG; Bailey CG; Rasko JE; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; McLean CA; Mitchell CA Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22231-6. PubMed ID: 21127264 [TBL] [Abstract][Full Text] [Related]
2. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC. Reed DE; Shokat KM Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852 [TBL] [Abstract][Full Text] [Related]
3. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Gewinner C; Wang ZC; Richardson A; Teruya-Feldstein J; Etemadmoghadam D; Bowtell D; Barretina J; Lin WM; Rameh L; Salmena L; Pandolfi PP; Cantley LC Cancer Cell; 2009 Aug; 16(2):115-25. PubMed ID: 19647222 [TBL] [Abstract][Full Text] [Related]
4. The INPP4B paradox: Like PTEN, but different. Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856 [TBL] [Abstract][Full Text] [Related]
5. A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms. Perez-Lorenzo R; Gill KZ; Shen CH; Zhao FX; Zheng B; Schulze HJ; Silvers DN; Brunner G; Horst BA J Invest Dermatol; 2014 May; 134(5):1359-1368. PubMed ID: 24288008 [TBL] [Abstract][Full Text] [Related]
6. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes. Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma. Yuen JW; Chung GT; Lun SW; Cheung CC; To KF; Lo KW PLoS One; 2014; 9(8):e105163. PubMed ID: 25126743 [TBL] [Abstract][Full Text] [Related]
8. The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis. Ooms LM; Binge LC; Davies EM; Rahman P; Conway JR; Gurung R; Ferguson DT; Papa A; Fedele CG; Vieusseux JL; Chai RC; Koentgen F; Price JT; Tiganis T; Timpson P; McLean CA; Mitchell CA Cancer Cell; 2015 Aug; 28(2):155-69. PubMed ID: 26267533 [TBL] [Abstract][Full Text] [Related]
9. Deletion of inositol polyphosphate 4-phosphatase type-II B affects spermatogenesis in mice. Ceyhan Y; Zhang M; Guo J; Sandoval CG; Vacher J; Kaftanovskaya EM; Agoulnik AI; Agoulnik IU PLoS One; 2020; 15(5):e0233163. PubMed ID: 32413098 [TBL] [Abstract][Full Text] [Related]
10. INPP4B: the new kid on the PI3K block. Agoulnik IU; Hodgson MC; Bowden WA; Ittmann MM Oncotarget; 2011 Apr; 2(4):321-8. PubMed ID: 21487159 [TBL] [Abstract][Full Text] [Related]
11. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway. Chen Y; Sun Z; Qi M; Wang X; Zhang W; Chen C; Liu J; Zhao W J Cell Mol Med; 2018 May; 22(5):2935-2943. PubMed ID: 29516642 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN. Ramírez-Moya J; Wert-Lamas L; Santisteban P Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3. Chaurasiya S; Wu W; Strom AM; Warner M; Gustafsson JÅ Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26347-26355. PubMed ID: 33020300 [TBL] [Abstract][Full Text] [Related]
14. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway. Li D; Yang J; Ma H; Sun C; Feng R J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953 [TBL] [Abstract][Full Text] [Related]
15. Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers. Thomas C; Henry W; Cuiffo BG; Collmann AY; Marangoni E; Benhamo V; Bhasin MK; Fan C; Fuhrmann L; Baldwin AS; Perou C; Vincent-Salomon A; Toker A; Karnoub AE Sci Signal; 2017 Feb; 10(467):. PubMed ID: 28223411 [TBL] [Abstract][Full Text] [Related]
16. INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas. Chi MN; Guo ST; Wilmott JS; Guo XY; Yan XG; Wang CY; Liu XY; Jin L; Tseng HY; Liu T; Croft A; Hondermarck H; Scolyer RA; Jiang CC; Zhang XD Oncotarget; 2015 Nov; 6(37):39891-907. PubMed ID: 26573229 [TBL] [Abstract][Full Text] [Related]
17. Phosphoinositide 3-kinase and INPP4B in human breast cancer. Bertucci MC; Mitchell CA Ann N Y Acad Sci; 2013 Mar; 1280():1-5. PubMed ID: 23551093 [TBL] [Abstract][Full Text] [Related]
18. Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer. Tokunaga E; Yamashita N; Kitao H; Tanaka K; Taketani K; Inoue Y; Saeki H; Oki E; Oda Y; Maehara Y Breast; 2016 Feb; 25():62-8. PubMed ID: 26577950 [TBL] [Abstract][Full Text] [Related]
19. Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells. Marty B; Maire V; Gravier E; Rigaill G; Vincent-Salomon A; Kappler M; Lebigot I; Djelti F; Tourdès A; Gestraud P; Hupé P; Barillot E; Cruzalegui F; Tucker GC; Stern MH; Thiery JP; Hickman JA; Dubois T Breast Cancer Res; 2008; 10(6):R101. PubMed ID: 19055754 [TBL] [Abstract][Full Text] [Related]
20. PTEN and Other PtdIns(3,4,5)P Csolle MP; Ooms LM; Papa A; Mitchell CA Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]